BioSpace News Archive

Policy

Lilly, Takeda Face Class-Action Racketeering Lawsuit Over Diabetes Drug

A class-action lawsuit from thousands of third-party payers alleges that the companies broke racketeering laws to market their diabetes drug Actos, while not disclosing its bladder cancer risk.

June 8, 2023
·
2 min read
·
Tristan Manalac
Business

Astellas Partners with Kate Therapeutics in Gene Therapy, After Four Patient Deaths in Previous Trials

Astellas Pharma will license and further develop a gene therapy from Kate Therapeutics aimed at addressing XLMTM amid safety concerns about its own experimental XLMTM treatment.

June 8, 2023
·
3 min read
·
Lisa Munger
Drug Development

Upstream Bio Adds Another $200M for Asthma, Allergy Pipeline

The company said Thursday it has closed $200 million in Series B financing—on top of last year’s $200 million Series A haul—to help initiate a registrational Phase II study for its lead candidate UPB-101.

June 8, 2023
·
2 min read
·
Tristan Manalac
Job Trends

Columbus, Cincinnati & Indianapolis Top List of Emerging Hubs for Researchers

A total of nine U.S. cities stood out in terms of total NIH funding in 2022.

June 8, 2023
·
4 min read
·
Rosemary Scott
Policy

FDA Action Alert: BMS, GSK, Ironwood, Ipsen/Albireo

The FDA has four target action dates this week for three supplemental approvals and one New Drug Approval.

June 8, 2023
·
5 min read
·
Tristan Manalac
Bitterroot Launches with $145M Series A to Advance Cardio-Immuno Therapies

The start-up’s lead program, BRB-002, is designed to target the CD47/SIRPα pathway and the underlying causes of vascular inflammation and atherosclerosis.

June 8, 2023
·
2 min read
·
Tristan Manalac
ASCO in Review: Oncologists See Practice-Changing, Affirming Data

With the 2023 American Society of Clinical Oncology meeting in the history books, BioSpace takes a look back at the presented data that oncologists think will be most practice-changing.

June 8, 2023
·
5 min read
·
Heather McKenzie
Biotech Beach

Zhaoke Ophthalmology Enters into Exclusive License, Supply and Distribution Agreement with Eyedetec Medical to Commercialize Eye Lipid Mobilizer™ for the Treatment of Dry Eye Disease

Zhaoke Ophthalmology Limited is pleased to announce that the Company has entered into an exclusive license, supply and distribution agreement with Eyedetec Medical, Inc., a leading US-based company specializing in medical devices for the treatment of dry eye disease and meibomian gland dysfunction.

June 8, 2023
·
5 min read
SurGenTec’s TiLink-L Receives FDA Clearance, Leading the Way as the First Offering in its Advanced Sacroiliac Joint Fusion Portfolio

A leader in innovative medical devices, is proud to announce clearance from the U.S. Food and Drug Administration for their proprietary TiLink-L Sacroiliac Joint Fusion System.

June 8, 2023
·
3 min read
Pharm Country

Celldex Therapeutics Announces Upcoming Barzolvolimab Presentations at EAACI 2023

Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced today that data from the Company’s barzolvolimab program will be presented at the European Academy of Allergy and Clinical Immunology (EAACI) Annual Congress 2023 being held June 9-11 in Hamburg, Germany.

June 8, 2023
·
3 min read